4 min read
In This Article:
Amid recent challenges in the UK’s stock market, highlighted by the FTSE 100’s decline due to weak trade data from China and falling commodity prices, investors are increasingly turning their attention to smaller, potentially overlooked companies that may offer unique opportunities. In this environment, identifying stocks with strong fundamentals and resilience against global economic pressures can be key to uncovering hidden gems in the UK market.
|
Name |
Debt To Equity |
Revenue Growth |
Earnings Growth |
Health Rating |
|---|---|---|---|---|
|
B.P. Marsh & Partners |
NA |
38.21% |
41.39% |
★★★★★★ |
|
BioPharma Credit |
NA |
7.22% |
7.91% |
★★★★★★ |
|
Goodwin |
22.59% |
10.66% |
18.55% |
★★★★★★ |
|
Bioventix |
NA |
7.39% |
5.15% |
★★★★★★ |
|
Rights and Issues Investment Trust |
NA |
-7.87% |
-8.41% |
★★★★★★ |
|
Andrews Sykes Group |
NA |
2.08% |
5.03% |
★★★★★★ |
|
Nationwide Building Society |
277.32% |
10.61% |
23.42% |
★★★★★☆ |
|
FW Thorpe |
2.95% |
11.79% |
13.49% |
★★★★★☆ |
|
Distribution Finance Capital Holdings |
9.15% |
50.88% |
67.63% |
★★★★★☆ |
|
AltynGold |
73.21% |
26.90% |
31.85% |
★★★★☆☆ |
Here’s a peek at a few of the choices from the screener.
Simply Wall St Value Rating: ★★★★★★
Overview: AdvancedAdvT Limited offers software solutions across Europe, the United Kingdom, North America, and internationally with a market capitalization of £259.74 million.
Operations: The company’s primary revenue stream is from its Blank Checks segment, generating £43.27 million.
AdvancedAdvT, a nimble player in the UK market, showcases impressive growth with earnings surging by 53.6% over the past year, outpacing its industry peers. The company reported sales of £43.27 million and net income of £10.88 million for the year ending February 2025, reflecting robust financial health without any debt burden for five years. Trading at 2.4% below its estimated fair value suggests potential undervaluation while maintaining high-quality earnings and free cash flow positivity adds to its appeal as a promising investment opportunity in the software sector despite recent delisting from OTC Equity due to inactivity.
-
Navigate through the intricacies of AdvancedAdvT with our comprehensive health report here.
-
Explore historical data to track AdvancedAdvT’s performance over time in our Past section.
Simply Wall St Value Rating: ★★★★★★
Overview: Science Group plc is a science and technology consultancy and systems business operating in the United Kingdom, other European countries, North America, and Asia, with a market capitalization of £251.74 million.
